{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:30:33Z","timestamp":1787506233008,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/paf.0000000000000082","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T04:35:36Z","timestamp":1390451736000},"page":"20-25","source":"Crossref","is-referenced-by-count":71,"title":["Pathological Findings in 2 Cases of Fatal 25I-NBOMe Toxicity"],"prefix":"10.1097","volume":"35","author":[{"given":"Jeffrey P.","family":"Walterscheid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett T.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana E.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morna L.","family":"Gonsoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcp.2007.07.018","article-title":"The behavioral pharmacology of hallucinogens.","volume":"75","author":"Fantegrossi","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/jm00222a001","article-title":"Synthesis and body distribution of several iodine-131 labeled centrally acting drugs.","volume":"20","author":"Braun","year":"1977","journal-title":"J Med Chem"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/mol.106.028720","article-title":"Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.","volume":"70","author":"Braden","year":"2006","journal-title":"Mol Pharmacol"},{"key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00259-010-1686-8","article-title":"Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.","volume":"38","author":"Ettrup","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2967\/jnumed.109.074021","article-title":"Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.","volume":"51","author":"Ettrup","year":"2010","journal-title":"J Nucl Med"},{"key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1016\/j.bmc.2008.04.050","article-title":"High specific activitytritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.","volume":"16","author":"Nichols","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jat\/bks084","article-title":"Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens.","volume":"37","author":"Guale","year":"2013","journal-title":"J Anal Toxicol"},{"key":"R8-7-20210126","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00000433-198803000-00008","article-title":"The forensic significance of conjunctival petechiae.","volume":"9","author":"Rao","year":"1988","journal-title":"Am J Forensic Med Pathol"},{"key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PAF.0b013e318165c77b","article-title":"Analysis of discrepancies between external body examination and forensic autopsy.","volume":"29","author":"Lorin de la Grandmaison","year":"2008","journal-title":"Am J Forensic Med Pathol"},{"key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/j.1556-4029.2009.01199.x","article-title":"Morbidity involving the hallucinogenic designer amines MDA and 2C-I.","volume":"54","author":"Drees","year":"2009","journal-title":"J Forensic Sci"},{"key":"R11-7-20210126","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.bjp.0704747","article-title":"Differences in potency and efficacy of a series of phenylisopropylaminephenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.","volume":"136","author":"Acuna-Castillo","year":"2002","journal-title":"Br J Pharmacol"},{"key":"R12-7-20210126","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/cmdc.200800133","article-title":"Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors.","volume":"3","author":"Blaazer","year":"2008","journal-title":"ChemMedChem"},{"key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens.","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol Ther"},{"key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0031-6997(25)06806-1","article-title":"Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system.","volume":"46","author":"McCall","year":"1994","journal-title":"Pharmacol Rev"},{"key":"R15-7-20210126","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0022-3565(25)39169-X","article-title":"Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity.","volume":"242","author":"McCall","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"R16-7-20210126","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0361-9230(01)00612-8","article-title":"Central cardiovascular regulation and 5-hydroxytryptamine receptors.","volume":"56","author":"Ramage","year":"2001","journal-title":"Brain Res Bull"},{"key":"R17-7-20210126","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tips.2008.06.009","article-title":"5-hydroxytryptamine and cardiovascular regulation.","volume":"29","author":"Ramage","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"R18-7-20210126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00210-007-0179-1","article-title":"Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptorsmechanisms involved and therapeutic implications.","volume":"376","author":"Villalon","year":"2007","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R19-7-20210126","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/15563650.2013.772191","article-title":"A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug.","volume":"51","author":"Rose","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"key":"R20-7-20210126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10822-010-9400-2","article-title":"Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor.","volume":"25","author":"Silva","year":"2011","journal-title":"J Comput Aided Mol Des"},{"key":"R21-7-20210126","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cbdv.200800235","article-title":"4-aryl-substituted 2,5-dimethoxyphenethylamines: synthesis and serotonin 5-HT(2A) receptor affinities.","volume":"6","author":"Trachsel","year":"2009","journal-title":"Chem Biodivers"},{"key":"R22-7-20210126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.forsciint.2012.08.027","article-title":"25C-NBOMenew potent hallucinogenic substance identified on the drug market.","volume":"227","author":"Zuba","year":"2012","journal-title":"Forensic Sci Int"}],"container-title":["American Journal of Forensic Medicine & Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAF.0000000000000082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:51:32Z","timestamp":1746103892000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000433-201403000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/paf.0000000000000082","relation":{},"ISSN":["0195-7910"],"issn-type":[{"value":"0195-7910","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}